Atlas Trials

Efficacy and Safety of Imatinib in Chordoma

Clinical trial NCT00150072 · COMPLETED

Trial details

NCT number
NCT00150072
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chordoma
Start date
2004-10-01
Primary completion
2008-04-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.